Small artery remodeling in hypertension and diabetes

Current Hypertension Reports

Volumn 8, Issue 1, 2006, Pages 90-95

  Rizzoni, Damiano ^a   Rosei, Enrico Agabiti ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM ANTAGONIST; CANDESARTAN; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; PERINDOPRIL; RENIN;

ARTERY MEDIA; ARTERY MUSCLE; ARTERY RESISTANCE; BLOOD VESSEL WALL; DATA ANALYSIS; DIABETIC HYPERTENSION; DRUG EFFICACY; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HUMAN; HYPERTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOOTH MUSCLE FIBER; VASCULARIZATION;

EID: 33646048598     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0046-3     Document Type: Review

References (38)

1. Mulvany MJ, Aalkjaer C: Structure and function of small arteries. Physiol Rev 1990, 70:921-971.
2. Mulvany MJ: Structural abnormalities of the resistance vasculature in hypertension. J Vasc Res 2003, 40:558-560.
3. Schiffrin EL: Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004, 17:1192-1200.
4. Christensen KL, Mulvany MJ: Location of resistance arteries. J Vasc Res 2001, 38:1-12.
5. Mulvany MJ: Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002, 17:105-109.
6. Aalkjaer C, Haegerty AM, Petersen KK, et al.: Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987, 61:181-186.
7. Schiffrin EL, Deng LY, Larochelle P: Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993 16:177-186.
8. Agabiti-Rosei E, Rizzoni D, Castellano M, et al.: Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995, 13:341-347.
9. Baumbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989, 13:968-972.
10. Heagerty AM, Aalkjaaer C, Bund SJ, et al.: Small artery structure in hypertension: dual process of remodeling and growth. Hypertension 1993, 21:391-397.
11. Mulvany MJ, Baumbach GL, Aalkjaer C, et al.: Vascular remodeling. Hypertension 1996, 28:505-506.
12. Bund SJ, Lee RMKW: Arterial structural changes in hypertension: a consideration of methodology, terminology and functional conseqences. J Vasc Res 2003, 40:547-557.
13. Rizzoni D, Porteri E, Castellano M, et al.: Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996, 28:785-790.
14. Rizzoni D, Porteri E, Guelfi D, et al.: Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000, 35:931-935.
15. McNally PG, Watt PAC, Rimmer T, et al.: Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci 1994, 87:31-36.
16. Rizzoni D, Porteri E, Guelfi D, et al.: Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin dependent diabetes mellitus. Circulation 2001, 103:1238-1244.
17. Schofield I, Malik R, Izzard A, et al.: Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106:3037-3043.
18. Lever AF: Slow pressor mechanisms in hypertension: A role for hypertrophy of resistance vessels? J Hypertens 1986, 4:515-524.
19. Korner PI, Bobik A, Jennings GL, et al.: Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Pharmacol 1991, 17(Suppl2):S25-S32.
20. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347-504.
21. Sivertsson R: The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 1970, 343:14-19.
22. Rizzoni D, Palombo C, Porteri E, et al.: Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003, 21:625-632.
23. Park JB, Schiffrin EL: Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001, 19:921-930.
24. Muiesan ML, Rizzoni D, Salvetti M, et al.: Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens 2002, 20:1439-1444.
25. Rizzoni D, Porteri E, Boari GEM, et al.: Prognostic significance of small artery structure in hypertension. Circulation 2003, 108:2230-2235.
26. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM: Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005, 23:247-250.
27. Sihm I, Schroeder AP, Aalkjaer C, et al.: Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen. Can J Cardiol 1994, 10(SupplD):30D-32D.
28. Thybo NK, Stephens N, Cooper A, et al.: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25(Pt 1):474-481.
29. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994, 23:83-91.
30. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995, 8:229-236.
31. Rizzoni D, Muiesan ML, Porteri E, et al.: Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997, 15:197-204.
32. Schiffrin EL, Deng LY: Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 1996, 14:1237-1244.
33. Sihm I, Schroeder AP, Aalkjaer C, et al.: Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens. Am J Hypertens 1998, 11:263-271.
34. Schiffrin EL, Park JB, Integan HD, Toyuz RM: Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonists losartan. Circulation 2000, 101:1653-1659.
35. Schiffrin EL, Park JB, Pu Q: Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 2002, 20:71-78.
36. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003, 21:1011-1053.
37. Endemann DH, Pu Q, De Ciuceis C, et al.: Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004, 43:399-404.
38. Rizzoni D, Porteri E, De Ciuceis C, et al.: Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with non insulin-dependent diabetes mellitus. Hypertension 2005, 45:659-665.